It’s 2025 and a growing number of pathologists is already convinced, that going digital is worth it. (If you’re still on the fence, read our Ultimate Guide: 10 Things You Should Know about the Transformational Impact of Digital Pathology). One...
High Content Imaging: Analyzing Ex-Vivo Drug Response Assays with MIKAIA
Researchers at the Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM) have developed PEDRA: Platform for Ex-Vivo Drug Response Assays. Up to 100 compounds are tested in parallel on primary patient...
April 14, 2025